Clinical aspects and treatments for pediatric inflammatory bowel diseases
The incidence of pediatric inflammatory bowel disease (IBD) is increasing worldwide, especially in the developing countries. It differs from adult disease in clinical manifestations, especially with regard to genetic predisposition in monogenic IBD. Pediatric disease also have a tendency to show mor...
Main Author: | Jin Soo Moon |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of Intestinal Diseases
2019-01-01
|
Series: | Intestinal Research |
Subjects: | |
Online Access: | http://www.irjournal.org/upload/pdf/ir-2018-00139.pdf |
Similar Items
-
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
by: Guanglin Cui, et al.
Published: (2021-04-01) -
Impact of diagnostic delay to the clinical presentation and associated factors in pediatric inflammatory bowel disease: a retrospective study
by: Emmiina Sulkanen, et al.
Published: (2021-10-01) -
Frequency and Effectiveness of Empirical Anti-TNF Dose Intensification in Inflammatory Bowel Disease: Systematic Review with Meta-Analysis
by: Laura Guberna, et al.
Published: (2021-05-01) -
Editorial: Pediatric Inflammatory Bowel Diseases: Looking to the Future
by: Eytan Wine, et al.
Published: (2020-02-01) -
Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review
by: Xiaojun Zhuang, et al.
Published: (2021-02-01)